| Prostatic Diseases |
NCT00636259: Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer |
|
|
| No Longer Available | N/A | | US | Bicalutamide (Casodex) | AstraZeneca | Adenocarcinoma of the Prostate | | | | |
TADS, NCT01007825: Testosterone-Guided Schedule of Androgen Deprivation Therapy (ADT) as an Alternative to A Fixed Schedule In Management Of Prostate Cancer |
|
|
| Not yet recruiting | N/A | 100 | NA | | University Health Network, Toronto | Prostate Cancer | 10/10 | 03/11 | | |
NCT01516762: Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases |
|
|
| No Longer Available | N/A | | US | Radium-223 dichloride (BAY88-8223) | Bayer | Prostatic Neoplasms | | | | |
|
NCT01777061: Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan |
|
|
| No Longer Available | N/A | | US | [11C]Acetate, carbon-11 acetate [[11C]acetate], sodium acetate [11C]Acetate injection | Wendell Yap, MD, University of Kansas Medical Center | Prostate Cancer | | | | |
NCT01834209: A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer |
|
|
| No Longer Available | N/A | | RoW | Abiraterone acetate, Prednisone or prednisolone | Janssen Research & Development, LLC | Prostate Neoplasms | | | | |
NCT02186925: A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. |
|
|
| Recruiting | N/A | 1000 | RoW | | Meir Medical Center | Kidney Cancer, Prostate Cancer, Bladder Cancer | 08/19 | 08/25 | | |
| Recruiting | N/A | 354 | Europe | questionnaire administration, assessment of therapy complications, high-intensity focused ultrasound ablation, multiparametric magnetic resonance imaging, quality-of-life assessment, transperineal prostate biopsy, transrectal prostate biopsy | University College, London | Male Erectile Disorder, Prostate Cancer, Therapy-related Toxicity, Urinary Incontinence | 12/28 | 06/29 | | |
